HomeNewscoronavirusSome Indian states warn of vaccine shortage as COVID-19 cases peak

Some Indian states warn of vaccine shortage as COVID-19 cases peak

Some states, including hardest-hit Maharashtra and Odisha, have complained of a scarcity of vaccines during a second wave that has forced some centres to turn away people.

April 07, 2021 / 22:27 IST
Some states, including hardest-hit Maharashtra and Odisha, have complained of a scarcity of vaccines during a second wave that has forced some centres to turn away people. (Representative Image)

India reported a record 115,736 new COVID-19 cases on Wednesday, a 13-fold increase in just over two months, raising pressure on the government to expand its vaccination campaign.

Some states, including hardest-hit Maharashtra and Odisha, have complained of a scarcity of vaccines during a second wave that has forced some centres to turn away people.

Only those aged over 45 are being immunised.

"Vaccination centres have to close early due to a shortage of supplies," the western state's health minister, Rajesh Tope, told reporters, adding that stocks would run out in three days after the daily injection of over 450,000 doses.

Also read: Health minister Harsh Vardhan blasts ‘some state governments’ for vaccination failures

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

India's health minister said the complaints, mostly from states not ruled by Prime Minister Narendra Modi's party, were attempts to cover up their failures and spread panic.

"Vaccine supplies are being monitored on a real-time basis, and state governments are being apprised regularly about it," Harsh Vardhan said in a statement.

"Allegations of vaccine shortage are utterly baseless.

To requests from states to widen the immunisation drive to include more adults, he said: "So long as the supply of vaccines remains limited, there is no option but to prioritise."

Maharashtra has for weeks accounted for over half India's daily new cases, which on Monday passed 100,000 for the first time. The government blames the resurgence mainly on crowding and a reluctance to wear masks as shops and offices reopen.

Maharashtra has urged the government to expand vaccinations to younger people and to divert medical oxygen from other regions, Tope said.

Maharashtra, Delhi, Punjab and Karnataka states have in recent days imposed new curbs, including night curfews in some places.

The federal government has refused to impose any national lockdown. The previous one last year devastated the economy and left millions penniless.

'NO SCOPE FOR COMPLACENCY'

India has recorded 12.8 million cases, the third worst-hit country after the United States and Brazil.

Deaths from COVID-19 rose by 630 – the most in four days – to 166,177, according to new health ministry data.

Daily infections have also passed last September's peak.

Many states have criticised the government as India, the world's biggest vaccine maker, has restricted its immunisation drive to some 400 million of its 1.35 billion people.

It has so far administered 86 million doses, 90% of those the AstraZeneca shot made by the Serum Institute of India. The rest have come from Indian company Bharat Biotech, which has struggled to boost output of its homegrown shot.

Both vaccines require two doses. More than 75 million people in India have received at least one dose. Only the United States and China have administered more doses.

With the contagion accelerating, India is racing to increase immunity. It has delayed exports of large quantities of vaccines, though 64.5 million doses have already been shipped.

"We are supposed to be the pharmacy of the world," said a government official who declined to be named. "What kind of pharmacy is this that cannot provide vaccines to even a small portion of its people?"

Reuters
first published: Apr 7, 2021 10:27 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347